{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:00:04Z","timestamp":1787007604759,"version":"build-2736575974"},"reference-count":27,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Food Additives &amp; Contaminants: Part A"],"published-print":{"date-parts":[[2024,1,2]]},"DOI":"10.1080\/19440049.2023.2292603","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T13:49:35Z","timestamp":1702648175000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Determination of N-nitroso folic acid in folic acid and multivitamin supplements by LC-MS\/MS"],"prefix":"10.1080","volume":"41","author":[{"given":"Yun","family":"Zeng","sequence":"first","affiliation":[{"name":"Pharmaceutical Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Teo","sequence":"additional","affiliation":[{"name":"Pharmaceutical Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Quan","family":"Lim","sequence":"additional","affiliation":[{"name":"Pharmaceutical Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Kiat","family":"Hoi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee-Leong","family":"Kee","sequence":"additional","affiliation":[{"name":"Pharmaceutical Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Yong","family":"Low","sequence":"additional","affiliation":[{"name":"Pharmaceutical Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Ge","sequence":"additional","affiliation":[{"name":"Pharmaceutical Laboratory, Applied Sciences Group, Health Sciences Authority, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/71.5.1304s"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1258\/0007142991902646"},{"key":"e_1_3_2_4_1","unstructured":"European Directorate for the Quality of Medicines & Healthcare [EDQM]. 2018. Ad-hoc projects of the OMCL network - Methods for determination of NDMA and NDEA in Sartans; [accessed 2023 Dec 04]. https:\/\/www.edqm.eu\/en\/ad-hoc-projects-omcl-network"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2014.3893"},{"key":"#cr-split#-e_1_3_2_6_1.1","unstructured":"European Medicines Agency [EMA]. 2021. European medicines regulatory network approach for the implementation of the CHMP opinion pursuant to article 5(3) of Regulation (EC) No 726\/2004 for nitrosamine impurities in human medicines"},{"key":"#cr-split#-e_1_3_2_6_1.2","unstructured":"[accessed 2023 Dec 04 Dec]. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/european-medicines-regulatory-network-approach-implementation-chmp-opinion-pursuant-article-53\/2004-nitrosamine-impurities-human-medicines_en.pdf"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119946045.ch21"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2014.01.009"},{"key":"#cr-split#-e_1_3_2_9_1.1","unstructured":"Health Sciences Authority [HSA]. 2019. HSA recalls three out of 46 metformin medicines"},{"key":"#cr-split#-e_1_3_2_9_1.2","unstructured":"[accessed 2023 Dec 04]. https:\/\/www.hsa.gov.sg\/announcements\/news\/hsa-recalls-three-out-of-46-metformin-medicines"},{"key":"e_1_3_2_10_1","unstructured":"ICH Q2(R1). 2005. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Validation of Analytical Procedures: Text and Methodology; [accessed 2023 Dec 08]. https:\/\/database.ich.org\/sites\/default\/files\/Q2%28R1%29%20Guideline.pdf"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3841.2009.01359.x"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271444"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2015.09.090"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48344-5"},{"key":"e_1_3_2_15_1","unstructured":"National Institute of Health [NIH]. 2022. Folate fact sheet for health professionals. [accessed 2023 Dec 04]. https:\/\/ods.od.nih.gov\/factsheets\/Folate-HealthProfessional\/"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.5487\/TR.2015.31.3.279"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1978.132"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoac\/84.5.1413"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/jf60225a048"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2011.06.024"},{"key":"e_1_3_2_21_1","unstructured":"United States Food and Drug Administration [U.S. FDA]. 2021. FDA updates and press announcements on nitrosamines in Rifampin and Rifapentine; [accessed 2023 Dec 04]. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-updates-and-press-announcements-nitrosamines-rifampin-and-rifapentine"},{"key":"e_1_3_2_22_1","unstructured":"United States Food and Drug Administration [U.S. FDA]. 2023. Updated information recommended acceptable intake limits for nitrosamine drug substance-related impurities (NDSRIs); [accessed 202304 Dec 2023]. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/updated-information-recommended-acceptable-intake-limits-nitrosamine-drug-substance-related"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.31003\/USPNF_M34237_02_01"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.31003\/USPNF_M15715_02_01"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7374.1202"},{"issue":"8","key":"e_1_3_2_26_1","first-page":"1981","article-title":"Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine","volume":"35","author":"Wogan GN","year":"1975","unstructured":"Wogan GN, Paglialunga S, Archer MC, Tannenbaum SR. 1975. Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine. Cancer Res. 35(8):1981\u20131984.","journal-title":"Cancer Res"}],"container-title":["Food Additives &amp; Contaminants: Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/19440049.2023.2292603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T21:49:17Z","timestamp":1727214557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/19440049.2023.2292603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"alternative-id":["10.1080\/19440049.2023.2292603"],"URL":"https:\/\/doi.org\/10.1080\/19440049.2023.2292603","relation":{},"ISSN":["1944-0049","1944-0057"],"issn-type":[{"value":"1944-0049","type":"print"},{"value":"1944-0057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tfac20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tfac20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}